Skip to content

Dose Optimization of Oral Ferric Dextran Solution for the Treatment of Mild to Moderate Iron Deficiency Anemia during Pregnancy: A Randomized Controlled Trial

Dose Optimization of Oral Ferric Dextran Solution for the Treatment of Mild to Moderate Iron Deficiency Anemia during Pregnancy: A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600122610
Enrollment
Unknown
Registered
2026-04-15
Start date
2026-04-15
Completion date
Unknown
Last updated
2026-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Iron Deficiency Anemia

Interventions

Experimental Group:Step-Down Iron Supplementation
Control Group:Conventional Iron Supplementation

Sponsors

The Third Affiliated Hospital of Guangzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1.Age 20–40 years; 2.Gestational age 12–28 weeks; 3.Laboratory-confirmed mild to moderate iron deficiency anemia (Hb 70–109 g/L and SF < 30 µg/L); 4.Willing to participate in the study and provide written informed consent.

Exclusion criteria

Exclusion criteria: 1.Presence of recurrent vaginal bleeding; Acute infection or liver/kidney dysfunction (transaminase or serum creatinine > 2x upper limit of normal); 2.Definite diagnosis of thalassemia, aplastic anemia, chronic kidney disease, or autoimmune disease; 3.Intolerance or history of allergy to iron dextran oral solution; 4.Any other condition that, in the investigator's judgment, makes the subject unsuitable for participation in the study.

Design outcomes

Primary

MeasureTime frame
Pre-delivery Hb Level;

Secondary

MeasureTime frame
Incidence of Adverse Reactions;

Countries

China

Contacts

Public ContactZhijian Wang

The Third Affiliated Hospital of Guangzhou Medical University

wzjnfyy@163.com+86 135 4455 7366

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 23, 2026